CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3475-3478

  Gauduin, Marie Claire ^a,d   Allaway, Graham P ^b,e   Olson, William C ^b   Weir, Raymond ^a   Maddon, Paul J ^b   Koup, Richard A ^a,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b A Subsidiary of Lantheus Holdings   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Manchester Biosciences Incubator   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 IMMUNOGLOBULIN; HYBRID PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

EID: 0031900546     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3475-3478.1998     Document Type: Article

References (21)

1. Allaway, G. P., K. L. Davis-Bruno, G. A. Beaudry, E. B. Garcia, E. L. Wong, A. M. Ryder, K. W. Hasel, M.-C. Gauduin, R. A. Koup, J. S. McDougal, and P. J. Maddon. 1995. Expression and characterization of CD4-IgG2, a novel heterotetramer that neutralizes primary HIV type 1 isolates. AIDS Res. Hum. Retroviruses 11:533-539.
2. Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphocyte retrovirus from patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220:868-871.
3. Cohen, J. 1993. Jitters jeopardize AIDS vaccine trials. Science 262:980-981.
4. Emini, E. A., W. A. Schleif, J. H. Nunberg, A. J. Conley, Y. Eda, S. Tokiyoshi, S. D. Putney, S. Matsushita, K. E. Cobb, C. M. Jett, J. W. Eichberg, and K. K. Murthy. 1992. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355:728-730.
5. Gauduin, M. C., G. P. Allaway, P. J. Maddon, C. F. Barbas, D. R. Burton, and R. A. Koup. 1996. Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules. J. Virol. 70:2586-2592.
6. Gauduin, M. C., P. W. H. I. Parren, R. Weir, C. F. Barbas, D. R. Burton, and R. A. Koup. 1997. Passive immunization with a potent neutralizing human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of human immunodeficiency virus type 1. Nat. Med. 3:1389-1393.
7. Gauduin, M. C., J. T. Safrit, R. Weir, M. S. Fung, and R. A. Koup. 1995. Pre- and post-exposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J. Infect. Dis. 171:1203-1209.
8. Harris, W. J. 1997. Therapeutic antibodies in infectious disease, p. 89-118. In W. J. Harris and J. R. Adair (ed.), Antibody therapeutics. CRC Press, Boca Raton, Fla.
9. Ho, D. D., T. Moudgil, and M. Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N. Engl. J. Med. 321:1621-1625.
10. Koup, R. A., and D. D. Ho. 1994. Quantitative culture assay for HIV-1 in peripheral blood, p. 107-112. In A. Aldovini and B. D. Walker, (ed.), Techniques in HIV research. Stockton Press, New York, N.Y.
11. Koup, R. A., R. M. Hesselton, J. T. Safrit, M. Somasundran, and J. L. Sullivan. 1994. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acute-infected Hu-PBL-SCID mice. AIDS Res. Hum. Retroviruses 10:279-284.
12. Koyanagi, Y., S. Miles, R. T. Milsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
13. Lambert, J. S., L. M. Mofenson, C. V. Fletcher, J. Moye, E. R. Stiehm, W. A. Meyer III, G. J. Nemo, B. J. Mathieson, G. Hirsch, C. V. Sapan, L. M. Cummins, E. Jiminez, E. O'Neill, A. Kovacs, A. Stek, and the Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group. 1997. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J. Infect. Dis. 175:283-291.
14. Mascola, J. R., J. Louwagie, F. E. McCutchan, C. L. Fischer, P. A. Hegerich, K. F. Wagner, A. K. Fowler, J. G. McNeil, and D. S. Burke. 1994. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 169:48-54.
15. Matthews, T. J. 1994. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res. Hum. Retroviruses 10:631-632.
16. Moore, J. P., Y. Cao, D. D. Ho, and R. A. Koup. 1994. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
17. Mosier, D. E., R. J. Gulizia, S. M. Baird, D. B. Wilson, D. H. Spector, and S. A. Spector. 1991. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791-794.
18. Parren, P. W. H. I., H. J. Ditzel, R. J. Gulizia, J. M. Binley, C. F. Barbas III, D. R. Burton, and D. E. Mosier. 1995. Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site. AIDS 9:F1-F6.
19. Prince, A. M., B. Horowitz, L. Baker, R. W. Shulman, H. Ralph, J. Valinsky, A. Cundell, B. Brotman, W. Boehle, F. Rey, M. Piet, H. Reesink, N. Lelie, M. Tersmette, F. Miedema, L. Barbosa, G. Nemo, C. L. Nastala, J. S. Allan, D. R. Lee, and J. W. Eichberg. 1988. Failure of an HIV immune globulin to protect chimpanzees against experimental challenge with HIV. Proc. Natl. Acad. Sci. USA 85:6944-6948.
20. Safrit, J. T., M. S. C. Fung, C. A. Andrews, D. G. Braun, W. N. C. Sun, T. W. Chang, and R. A. Koup. 1993. Hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS 7:15-21.
21. Trkola, A., A. P. Pomales, H. Yuan, B. Korber, P. J. Maddon, G. Allaway, B. Katinger, C. F. Barbas, D. R. Burton, D. D. Ho, and J. P. Moore. 1995. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-immunoglobulin G. J. Virol. 69:6609-6617.